98
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Quantitative Adherence Level Evaluation Among Long-Term Antiretroviral Therapy Patients in Latvia

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 3147-3154 | Received 30 Aug 2023, Accepted 21 Nov 2023, Published online: 05 Dec 2023

References

  • World Health Organization. HIV and AIDS. Available from: https://www.who.int/news-room/fact-sheets/detail/hiv-aids. Accessed July 26, 2023.
  • World Health Organization. HIV/AIDS Surveillance in Europe 2022 – 2021 Data. Vol. 03. World Health Organization; 2022. doi:10.2900/818446
  • Latvian Centre for Disease Prevention and Control. HIV/AIDS statistics. Available from: https://www.spkc.gov.lv/lv/hivaids-statistika. Accessed July 26, 2023.
  • Peña Donati A, Laufer M. Acquired Immune Deficiency Syndrome. In: Pediatric Respiratory Diseases: A Comprehensive Textbook. StatPearls Publishing; 2020:517–528. doi:10.1007/978-3-030-26961-6_51
  • Menéndez-Arias L, Delgado R. Update and latest advances in antiretroviral therapy. Trends Pharmacol Sci. 2022;43(1):16–29. doi:10.1016/j.tips.2021.10.004
  • Pasternak AO, Berkhout B. HIV persistence: silence or resistance? Curr Opin Virol. 2023;59. doi:10.1016/j.coviro.2023.101301
  • Shahzad M, Chen H, Akhtar T, Rafi A, Zafar MS, Zheng YT. Human immunodeficiency virus: the potential of medicinal plants as antiretroviral therapy. J Med Virol. 2022;94(6):2669–2674. doi:10.1002/jmv.27648
  • Annor FB, Chiang LF, Oluoch PR, et al. Changes in prevalence of violence and risk factors for violence and HIV among children and young people in Kenya: a comparison of the 2010 and 2019 Kenya violence against children and youth surveys. Lancet Glob Heal. 2022;10(1):e124–e133. doi:10.1016/S2214-109X(21)00457-5
  • Poorolajal J, Hooshmand E, Mahjub H, Esmailnasab N, Jenabi E. Survival rate of AIDS disease and mortality in HIV-infected patients: a meta-analysis. Public Health. 2016;139:3–12. doi:10.1016/j.puhe.2016.05.004
  • Gueler A, Moser A, Calmy A, et al. Life expectancy in HIV-positive persons in Switzerland: matched comparison with general population. AIDS. 2017;31(3):427–436. doi:10.1097/QAD.0000000000001335
  • Teeraananchai S, Kerr SJ, Amin J, Ruxrungtham K, Law MG. Life expectancy of HIV-positive people after starting combination antiretroviral therapy: a meta-analysis. HIV Med. 2017;18(4):256–266. doi:10.1111/hiv.12421
  • Marcus JL, Chao CR, Leyden WA, et al. Narrowing the gap in life expectancy between HIV-Infected and HIV-uninfected individuals with access to care. J Acquir Immune Defic Syndr. 2016;73(1):39–46. doi:10.1097/QAI.0000000000001014
  • Esté JA, Cihlar T. Current status and challenges of antiretroviral research and therapy. Antiviral Res. 2010;85(1):25–33. doi:10.1016/j.antiviral.2009.10.007
  • Rodger AJ, Cambiano V, Phillips AN, et al. Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study. Lancet. 2019;393(10189):2428–2438. doi:10.1016/S0140-6736(19)30418-0
  • Altice F, Evuarherhe O, Shina S, Carter G, Beaubrun AC. Adherence to HIV treatment regimens: systematic literature review and meta-analysis. Patient Prefer Adher. 2019;13:475–490. doi:10.2147/PPA.S192735
  • Neupane S, Dhungana GP, Ghimire HC. Adherence to antiretroviral treatment and associated factors among people living with HIV and AIDS in CHITWAN, Nepal. BMC Public Health. 2019;19(1):1–9. doi:10.1186/s12889-019-7051-3
  • Goldschmidt RH, Chu C, Dong BJ. Initial management of patients with HIV infection. Am Fam Physician. 2016;94(9):708–716.
  • Bekker LG, Alleyne G, Baral S, et al. Advancing global health and strengthening the HIV response in the era of the sustainable development goals: the international AIDS society—lancet commission. Lancet. 2018;392(10144):312–358. doi:10.1016/S0140-6736(18)31070-5
  • Astuti N, Maggiolo F. Single-tablet regimens in HIV therapy. Infect Dis Ther. 2014;3(1):1–17. doi:10.1007/s40121-014-0024-z
  • World Health Organization. Adherence to long-term therapies. Evidence for Action; 2003. Available from: http://www.who.int/chp/knowledge/publications/adherence_introduction.pdf%0Ahttp://www.who.int/chp/knowledge/publications/adherence_introduction.pdf?ua=1%0Ahttp://www.who.int/chp/knowledge/publications/adherence_introduction.pdf. Accessed July 27, 2023.
  • McComsey GA, Lingohr-Smith M, Rogers R, Lin J, Donga P. Real-world adherence to antiretroviral therapy among HIV-1 patients across the United States. Adv Ther. 2021;38(9):4961–4974. doi:10.1007/s12325-021-01883-8
  • Kalungwe M, Mbalinda SN, Karonga T, Simwanza NR, Mumba Mtambo CM, Nyashanu M. Exploring barriers to antiretroviral therapy adherence among pregnant women: a scoping literature review. Int J Gynecol Obstet. 2022;159(2):343–350. doi:10.1002/ijgo.14130
  • Daltro ACB, Almeida CS, Unfried AGC, de Aquino TR, Travassos AGÁ. Virological failure and adherence to antiretroviral therapy in adolescents and young adults living with human immunodeficiency virus. Trop Med Int Heal. 2023;28(3):162–174. doi:10.1111/tmi.13854
  • Ministry of Health of Latvia. Adopt new rules to prevent and limit the spread of HIV. Available from: https://www.vm.gov.lv/lv/jaunums/pienem-jaunus-noteikumus-hiv-profilaksei-un-izplatibas-ierobezosanai. Accessed November 5, 2023.
  • Ministry of Health of Latvia. PROTOCOL No. 35 of the meeting of the coordination commission for limiting the spread of HIV infection, tuberculosis and sexually transmitted infections. Available from: https://www.vm.gov.lv/lv/media/2377/download?attachment. Accessed November 6, 2023.
  • The National Health Service of Latvia. Reimbursement Medicine Lists. Available from: https://www.vmnvd.gov.lv/lv/kompensejamo-zalu-saraksti. Accessed November 5, 2023.
  • Kim J, Lee E, Park BJ, Bang JH, Lee JY. Adherence to antiretroviral therapy and factors affecting low medication adherence among incident HIV-infected individuals during 2009–2016: a nationwide study. Sci Rep. 2018;8(1):3133. doi:10.1038/s41598-018-21081-x
  • Lam WY, Fresco P. Medication adherence measures: an overview. Biomed Res Int. 2015;2015:1–12. doi:10.1155/2015/217047
  • Anghel LA, Farcas AM, Oprean RN. An overview of the common methods used to measure treatment adherence. Med Pharm Reports. 2019;92(2):117–122. doi:10.15386/mpr-1201
  • Nassar RI, Basheti IA, Saini B. Exploring validated self-reported instruments to assess adherence to medications used: a review comparing existing instruments. Patient Prefer Adher. 2022;16:503–513. doi:10.2147/PPA.S352161
  • Tibble H, Sheikh A, Tsanas A. Estimating medication adherence from electronic health records: comparing methods for mining and processing asthma treatment prescriptions. BMC Med Res Methodol. 2023;23(1):1–11. doi:10.1186/s12874-023-01935-3
  • Prieto-Merino D, Mulick A, Armstrong C, et al. Estimating proportion of days covered (PDC) using real-world online medicine suppliers’ datasets. J Pharm Policy Pract. 2021;14(1):1–14. doi:10.1186/s40545-021-00385-w
  • Asamoah-Boaheng M, Bonsu KO, Farrell J, Oyet A, Midodzi WK. Measuring medication adherence in a population-based asthma administrative pharmacy database: a systematic review and meta-analysis. Clin Epidemiol. 2021;13:981–1010. doi:10.2147/CLEP.S333534
  • Canfield SL, Zuckerman A, Anguiano RH, et al. Navigating the wild west of medication adherence reporting in specialty pharmacy. J Manag Care Spec Pharm. 2019;25(10):1073–1077. doi:10.18553/jmcp.2019.25.10.1073
  • Rathbun RC, Lewis MM, Yuet WC, Woo S, Miller JL, Skrepnek GH. The medication possession ratio as a predictor of longitudinal HIV-1 viral suppression. Ann Pharmacother. 2023;57(11):1264–1272. doi:10.1177/10600280231156624
  • Loucks J, Zuckerman AD, Berni A, Saulles A, Thomas G, Alonzo A. Proportion of days covered as a measure of medication adherence. Am J Heal Pharm. 2022;79(6):492–496. doi:10.1093/ajhp/zxab392
  • Pharmacy Quality Alliance. PQA measures: overview types of PQA measure; 2022.
  • Murphy P, Cocohoba J, Tang A, Pietrandoni G, Hou J, Guglielmo BJ. Impact of HIV-specialized pharmacies on adherence and persistence with antiretroviral therapy. AIDS Patient Care STDS. 2012;26(9):526–531. doi:10.1089/apc.2012.0189
  • Bezabhe WM, Chalmers L, Bereznicki LR, Peterson GM. Adherence to antiretroviral therapy and virologic failure. Medicine. 2016;95(15):e3361. doi:10.1097/MD.0000000000003361
  • Byrd KK, Hou JG, Hazen R, et al. Antiretroviral adherence level necessary for HIV viral suppression using real-world data. J Acquir Immune Defic Syndr. 2019;82(3):245–251. doi:10.1097/QAI.0000000000002142
  • Harrison JE, Weber S, Jakob R, Chute CG. ICD-11: an international classification of diseases for the twenty-first century. BMC Med Inform Decis Mak. 2021;21(1):21. doi:10.1186/s12911-021-01534-6
  • McMahon JH, Jordan MR, Kelley K, et al. Pharmacy adherence measures to assess adherence to antiretroviral therapy: review of the literature and implications for treatment monitoring. Clin Infect Dis. 2011;52(4):493–506. doi:10.1093/cid/ciq167
  • Latvian Association of Sociologists. Latvian association of sociologists professional code for conducting social and market research; 2008. Available from: http://sociologija.lv/etika-2/lsa-kodekss/. Accessed November 5, 2023.
  • Rutkovska I, Seilis A, Neikena Z, Poplavska E. Impact of risk minimisation measures on valproate use among women of reproductive age in Latvia between 2013 and 2020: a 7-year nationwide prescription database study. Drugs Real World Outcome. 2023;10(1):1–11. doi:10.1007/s40801-023-00394-y
  • Nachega JB, Hislop M, Dowdy DW, et al. Adherence to highly active antiretroviral therapy assessed by pharmacy claims predicts survival in HIV-infected South African adults. J Acquir Immune Defic Syndr. 2006;43(1):78–84. doi:10.1097/01.qai.0000225015.43266.46
  • Mills EJ, Nachega JB, Buchan I, et al. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA. 2006;296(6):679–690. doi:10.1001/jama.296.6.679